Skip to main content

Reversibility of Diabetic Cardiomyopathy by Therapeutic Interventions in Mild Diabetes

  • Chapter
  • 45 Accesses

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 130))

Abstract

Severe experimental diabetes, induced by streptozotocin in a dose of 65 mg/kg body weight, resulting in blood glucose levels of 500 mg/dl, leads to a cardiomyopathy, characterized by reduced cardiac output, due to reduced stroke volume and reduced heart rate. Investigating these hearts in the isolated working rat heart model, the development of a cardiomyopathy can be seen after 1 week of diabetes as well as after 2 weeks, 8 weeks, 16 and 24 weeks (1,2,3).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stroedter D, Willmann P, Willmann J, Federlin K, and Schaper W. Results of a balance of energy in the diabetic heart. In: The Diabetic Heart, eds. Nagano M and Dhalla NS, Raven Press, New York, pp 383–393, 1991.

    Google Scholar 

  2. Stroedter D, Schuster KR, Mogk M, Bretzel RG, and Federlin K. Reversibility of diabetic cardiomyopathy with islet transplantation in rats. Diabetes 1989;38ZSuppl 1:319–320.

    Google Scholar 

  3. Stroedter D. Diabetische Kardiomyopathie-Tatsache oder Fiktion? Habilitationsschrift, Univ. Giessen, FRG, 1987, pp 1–334.

    Google Scholar 

  4. Tahiliani AG, Lopaschuk GD and McNeill JH. Effect of insulin treatment on long-term diabetes-induced alteration of myocardial function. Gen Pharmacol 1984;15:545–547.

    Article  PubMed  CAS  Google Scholar 

  5. Tahiliani AG and McNeill JH. Diabetes-induced abnormalities in the myocardium. Life Sci 1986;38:959–974.

    Article  PubMed  CAS  Google Scholar 

  6. Neely JR, Liebermeister H, Battersby EJ and Morgan HE. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol 1967;212:804–812.

    PubMed  CAS  Google Scholar 

  7. Taegtmeyer H, Hems R and Krebs HA. Utilization of energy-providing substrates in the isolated working rat heart. Biochem J 1980;186:701–711.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Stroedter, D., Schmitt, M., Broetz, T., Federlin, K., Schaper, W. (1992). Reversibility of Diabetic Cardiomyopathy by Therapeutic Interventions in Mild Diabetes. In: Nagano, M., Mochizuki, S., Dhalla, N.S. (eds) Cardiovascular Disease in Diabetes. Developments in Cardiovascular Medicine, vol 130. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3512-6_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3512-6_30

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6558-7

  • Online ISBN: 978-1-4615-3512-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics